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ABSTRACT
Trypanosoma brucei mono-allelically expresses one
of approximately 1500 variant surface glycoprotein
(VSG) genes while multiplying in the mammalian
bloodstream. The active VSG is transcribed by
RNA polymerase I in one of approximately 15 telo-
meric VSG expression sites (ESs). T. brucei is
unusual in controlling gene expression predomin-
antly post-transcriptionally, and how ESs are
mono-allelically controlled remains a mystery. Here
we identify a novel transcription regulator, which re-
sembles a nucleoplasmin-like protein (NLP) with an
AT-hook motif. NLP is key for ES control in blood-
stream form T.brucei, as NLP knockdown results
in 45- to 65-fold derepression of the silent VSG221
ES. NLP is also involved in repression of transcrip-
tion in the inactive VSG Basic Copy arrays,
minichromosomes and procyclin loci. NLP is
shown to be enriched on the 177- and 50-bp
simple sequence repeats, the non-transcribed
regions around rDNA and procyclin, and both
active and silent ESs. Blocking NLP synthesis
leads to downregulation of the active ES, indicating
that NLP plays a role in regulating appropriate levels
of transcription of ESs in both their active and silent
state. Discovery of the unusual transcription regula-
tor NLP provides new insight into the factors that
are critical for ES control.
INTRODUCTION
An intriguing puzzle in transcriptional control is how or-
ganisms control the expression of very large numbers of
highly similar genes in a mono-allelic fashion. Examples
include regulation of the mammalian olfactory receptor
family, in which an individual neuron has more than
1200 olfactory receptor genes, of which only one is
activated at a time (1). This mono-allelic expression has
been proposed to involve the interaction of the active
receptor gene promoter with an activating H-enhancer
element, although whether this event regulates the
‘counting’ observed remains controversial (2,3). Parasitic
protozoa like the malaria parasite Plasmodium falciparum
also mono-allelically express only one out of approxi-
mately 50 VAR genes encoding the VAR proteins
present on the surface of the parasitized erythrocyte (4).
Activation of a VAR promoter alone is sufﬁcient for
silencing endogenous VAR transcription (5,6), while a
role for the VAR introns in mutually exclusive VAR
expression remains controversial (4,7).
Similarly, the African trypanosome Trypanosoma brucei
contains more than 1500 variant surface glycoprotein
(VSG) genes of which one is mono-allelically expressed
(8–10). T.brucei is the causative agent of African trypano-
somiasis in humans, which is endemic to sub-Saharan
Africa and is transmitted by tsetse ﬂies. Central to its
success as an extracellular pathogen is a protective VSG
coat which is antigenically varied during the course of an
infection. Key for antigenic variation to work, is the
ability of an individual trypanosome to ensure that only
one VSG is expressed at a time from one of approximately
15 telomeric ESs (11,12). A stringent control operates on
the active ES. Selection for simultaneous full activation of
a second ES is not tolerated, and leads to trypanosomes
which appear to be alternately switching between the two
ESs (13). In insect form T.brucei all ESs are to a great
extent transcriptionally downregulated, although not to
the degree observed in silent ESs in bloodstream form
T.brucei (14,15). It is still mysterious how the ‘counting’
machinery behind the mono-allelic transcription of VSG
ESs in bloodstream form T.brucei is mediated.
Initially, it was not apparent that changes in chromatin
structure played a signiﬁcant role in ES regulation in
bloodstream T.brucei. For example, experiments using ex-
ogenous T7 RNA polymerase as a probe showed a likely
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in bloodstream form T.brucei where the mono-allelic ex-
clusion of ESs operates (16). This viewpoint has recently
been revisited. Active ESs in bloodstream form T.brucei
have recently been shown to be highly depleted of nucleo-
somes compared with silent ESs (17,18). In addition, a
number of proteins involved in epigenetic regulation
have recently been shown to be instrumental for
controlling ESs in bloodstream form T.brucei. These
include T.brucei ISWI (member of the SNF2 superfamily
of chromatin remodeling proteins) (19), the telomere
binding protein RAP1 (20) and the histone modiﬁcation
enzyme DOT1B (21).
Here, we identify a novel protein with nucleoplasmin-
like features (nucleoplasmin-like protein—NLP) as
playing a key role in regulation of ESs in bloodstream
form T.brucei. Knockdown of NLP results in 45- to
65-fold derepression of the silent VSG221 ES. NLP is
also implicated in silencing other transcriptionally
inactive areas of the genome in bloodstream form
T.brucei including the silent VSG Basic Copy arrays,
minichromosomes and procyclin loci. We also ﬁnd that
after blocking NLP synthesis fully processive transcription
of the active ES is compromised. NLP therefore plays a
role in regulating appropriate transcription of ESs in both
their active and inactive states.
MATERIALS AND METHODS
Trypanosome strains and culturing
Bloodstream form T.brucei brucei 427 was used for all
experiments. Cells were cultured at 37 C with 5% CO2
in HMI-9 medium supplemented with 20% fetal bovine
serum (22). The T.brucei T3-NLP1 and T.brucei
T3-NLP2 clones are cell lines which have the
MC
177NLP RNAi construct integrated into
minichromosomes in bloodstream form T.brucei T3-SM
(19). These cells have an active VSGT3 expression site
(ES), and eGFP in the silent VSG221 ES (19).
Maintaining these cells on blasticidin selection allows the
propagation of a population of trypanosomes homoge-
neous for expression of VSGT3. The T.brucei 121-NLP1
and T.brucei 121-NLP2 clones are analogous cell lines,
but express VSG121 instead of VSGT3.
The T.brucei MCEP reporter cell line has a construct
containing eGFP (Clontech) behind an ES promoter that
is inserted into a minichromosome. The T.brucei VBEP
reporter cell line contains eGFP behind an ES promoter
that is inserted into a VSG Basic Copy array. The T. brucei
EP1eGFP cell line has a construct containing eGFP
inserted behind an endogenous EP1 procyclin promoter.
These reporter cell lines were created in a derivative of the
T.brucei ‘single marker’ cell line (23) where the
pHNES221Pur1.6 construct containing the puromycin re-
sistance gene is inserted immediately behind the active
VSG221 ES promoter. The MC
177NLP RNAi construct
was inserted into these different reporter lines, and dere-
pression of eGFP was monitored after the induction of
NLP RNAi using tetracycline.
Epitope tagging of NLP with the haemagglutinin (HA)
epitope was performed using T.brucei 221GPI(VO2+)
which has an active VO2 ES containing a neomycin resist-
ance gene, and eGFP and a puromycin resistance gene in
the silent VSG221 ES (24). This cell line was transfected
with the pMOTagHA–NLP construct to produce T.brucei
HA–NLP (25). Knocking out the second NLP allele was
performed by transfecting with the pBSphleoNLPKO
construct to produce T.brucei HA–NLPKO. As
knocking out the second NLP allele did not lead to an
observable effect on growth, this indicates that the HA
epitope tagged copy of NLP is fully functional.
Sequence analysis
Trypanosoma brucei NLP (accession number
Tb927.10.5450) protein domains were identiﬁed using
MyHits (ISB-SIB) and PROSITE. T.brucei NLP was
compared with Saccharomyces cerevisiae Swi2p/Snf2p (ac-
cession number NM_001183709.1), Arabidopsis thaliana
HMG-I/Y (accession number Y10836.1), Drosophila
melanogaster Nucleoplasmin (Nlp) (accession number
NP_524557), ISWI (accession number NM_078995.1)
and D1 (accession number NM_079562.2), Dario rerio
Nucleoplasmin2 (accession number NM_001123007.2),
Xenopus laevis Nucleoplasmin2 (accession number
BC157168.1) and Nucleoplasmin3 (accession number
NM_001016456.2), Mus musculus Nucleoplasmin1 (acces-
sion number BC090843.1), Nucleoplasmin3 (accession
number NM_008723.1) and HMGI-C (accession number
NM_010441.2), and Homo sapiens Nucleoplasmin3 (ac-
cession number NM_006993.2) and HMG-I/HMG-Y (ac-
cession number NM_145899.2) using ClustalW (26).
T.brucei TDP1 (accession number Tb927.3.3490) had
earlier been identiﬁed as binding the ES promoter by (27).
DNA constructs
The MC
177NLP RNAi construct has an 835-bp fragment
(positions 1522–2356) of the NLP open reading frame,
which was ampliﬁed using primers 50- tttgctcgagCGATG
CTTGTGTCCG and 50- gacaggatccTTGAGGCGGTTA
CTG and inserted between the opposing T7 promoters of
the p2T7
Ti-177 construct (28). The MCEP reporter con-
struct has the ES promoter from rDES1 (14) upstream of
eGFP with ﬂanking tubulin RNA processing signals (29)
and a blasticidin resistance gene. This construct can be
inserted into T.brucei minichromosomes using the
177-bp repeat containing sequence from the p2T7
Ti-177
construct (28). The VBEP reporter construct has the ES
promoter upstream of eGFP as described above, targeted
into the VSG118 Basic Copy array. The VSG118 Basic
Copy array targeting fragment was PCR ampliﬁed from
T.brucei 427 genomic DNA using primers 50-tatggatccCT
TAAGTGAGCCAACACACCAG and 50-ctggaattcCTG
ACGAACCTCTAGTTACCG. The EP1 reporter con-
struct has eGFP as described above targeted behind an
endogenous EP1 procyclin promoter. The EP1 procyclin
targeting fragment was PCR ampliﬁed from T.brucei
genomic DNA using primers: 50-TCAGTGGTTGTGTG
GTAG and 50-TACTTCTTGGTGTAATTGAAGT.
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tagging NLP was derived from the pMOTag4H vector
(25). A 2163-bp fragment (positions 708–2871) of the
NLP open reading frame was cloned using primers
50-gttggtaccTCTCCTGAACACGGGACTTTCAC and
50-caactcgagCAACTCcAG-CCTTAGCTTGTTC. The
pBSphleoNLPKO vector allowed the genetic knockout
of an NLP allele. A 492-bp fragment immediately
upstream of the NLP open reading frame was ampliﬁed
using primers 50-tagtctagaGTGATTACATTCCCTACT
TTC and 50-agggatccTTATCCGCCTGGTACTTCCCT.
Similarly a 645-bp downstream targeting fragment was
ampliﬁed using primers: 50-tagaagcttTGGGTGTTAGG
AAACCTTCAA and 50-tagctcgagTCACCAAGCAAAT
CAATACGA. Construct integration into the genome
allowed the replacement of NLP sequences with a
phleomycin resistance cassette.
The His-tagged NLP fusion protein used for immuniza-
tion of rabbits to produce a polyclonal anti-NLP antibody
was made by amplifying a 597-bp fragment (positions
880–1476) of the NLP open reading frame using
primers: 50-catggatccGTCACCACCAGTCTCAACCAG
and 50-catctcgagGAGATCGCTGTAGTACACAGG
and inserting this fragment into the pRSETA vector
(Invitrogen) for expression in Escherichia coli.
Analysis of nucleic acids and protein
Protein lysates were made by washing cells, and dissolving
the pellet in boiling hot SDS gel loading buffer at a con-
centration of 10
5 cellsml
 1 (30). Protein lysates were
incubated at 100 C for 10min prior to loading on 10%
SDS polyacrylamide gels. Gels were blotted on to
Hybond-P membrane (Amersham) and probed with
rabbit polyclonal antibodies raised against NLP, BiP
(gift of Jay Bangs, University of Wisconsin, USA) or
HA epitope tag (ab9110 AbCam). Polyclonal anti-NLP
antibody was raised in rabbits immunised against
His-tagged NLP fusion protein (positions 880–1476 of
the NLP open reading frame). Recombinant fusion
protein was expressed in BL21(DE3)pLysS cells [OneShot
BL21(DE3)pLysS, Invitrogen] and then puriﬁed using
denaturing conditions with the ProBond puriﬁcation
system (Invitrogen) according to manufacturer’s instruc-
tions. Antisera were produced by Eurogentec (Belgium)
using standard immunization protocols.
Subnuclear localisation of NLP was determined using
immunoﬂuorescence microscopy. Cells were washed, ﬁxed
with paraformaldehyde (end concentration 2%) and then
allowed to settle on glass slides. Fixed cells were
permeabilized with 0.1% NP-40, and then reacted with a
rabbit polyclonal anti-HA antibody (ab9110, AbCam)
and an anti-rabbit secondary antibody coupled to
Alexa-488 (Molecular Probes). Microscopy was per-
formed using a Zeiss Axioplan 2 microscope, and images
were taken using a Roper Scientiﬁc (Trenton, NJ) Cool
Snap HQ camera, and analysed with Metamorph 6.20
imaging software (Universal Imaging, Downington, PA).
Transcript levels were quantitated using quantitiative
RT–PCR. RNA was isolated using RNeasy kits
(Qiagen). RNA was DNase treated using Turbo DNA
Free kit (Ambion) and cDNA synthesised using
Omniscript Reverse Transcriptase (Qiagen) and random
hexamer primers (Promega). Quantitative PCR (qPCR)
was performed as described in ref. (18) on a Roche
LightCycler480 Real-Time PCR system using primers
optimized for producing a single amplicon of the correct
size and listed in Supplementary Table S1 or ref. (18).
Transcript levels at each time point were normalized to
levels of actin transcript at that time point for experiments
using the VSGT3 expressors, and g-tubulin for experi-
ments using the VSG121 expressors, and then plotted as
fold increase with respect to the 0h time point.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed as
described in (18) with minor modiﬁcations. Bloodstream
form cells were ﬁxed for 1h in 1% formaldehyde at room
temperature. Glycine was added to a ﬁnal concentration
of 125mM to stop the reaction. Chromatin was sheared
by sonication (BioRuptor, Diagenode) to produce DNA
in the range of 200–500bp, and the extract was clariﬁed by
centrifugation at 15000g at 4 C. The solution was
pre-cleared by incubation with protein A-Sepharose
CL-4B beads (GE Healthcare) for 90min at 4 C before
incubation with the relevant antibody (or with ‘no
antibody’ as negative control) for 16h. Antibodies used
include a mouse monoclonal antibody against the HA
epitope (antibody ab1424, AbCam) and anti-histone H3
(ab1791, AbCam). Each experiment was performed in
triplicate and further analysis of ChIP material was per-
formed by quantitative PCR (qPCR). ChIP material was
analysed by qPCR using primers optimized for producing
a single amplicon of the correct size and are listed in (18)
or in Supplementary Table S1. Final quantitation of HA-
epitope tagged ChIP material in the T. brucei HA–NLP or
wild-type cell lines was obtained after subtracting values
derived from material immunoprecipitated with the cor-
responding ‘no antibody’ control experiments from both
of these cell lines. ChIP material was slot blotted on to
Hybond-XL membranes (GE Healthcare) and hybridized
with radio-labelled probes as described previously (18).
Flow cytometry
RNAi against NLP was induced in T.brucei by the
addition of 750ngml
 1 tetracycline. Cells were centri-
fuged and washed at speciﬁed time points. Flow cytometry
was carried out using a Becton-Dickinson FACSCalibur
and CellQuest (BD) software. The amount of derepression
was expressed as fold derepression, and calculated by
dividing mean FL1-H values of RNAi-induced cultures
at each time point by the mean FL1-H values of
uninduced cultures.
RESULTS
NLP is a nucleoplasmin-like protein which is essential in
bloodstream form T.brucei
We initially identiﬁed T.brucei NLP in DNA afﬁnity chro-
matography experiments as binding the transcriptionally
silent 177-bp simple sequence repeats, which comprise the
2020 Nucleic Acids Research, 2011,Vol.39, No. 6bulk of the T.brucei minichromosomes (accession number
Tb927.10.5450) (V. Tilston and K.E., unpublished data).
NLP shows little sequence similarity with proteins
in non-Kinetoplastid protozoa, but contains a
nucleoplasmin-like domain (e=2.3 10
 3) as well as a
DNA binding AT-hook motif (e=9.8 10
 3) (MyHits;
ISB-SIB) (Figure 1A). A characteristic glutamate-rich
region (e=3.8 10
 9) extends approximately from
residues 600–670, partially overlapping the
nucleoplasmin-like domain (PROSITE). Additionally,
two coiled-coil regions extend between residues 429–458
and 586–691 (SMART, EMBL).
Nucleoplasmin was ﬁrst identiﬁed in Xenopus oocytes as
a highly abundant nuclear protein and has since been
found in other higher eukaryotes (31,32). We aligned
NLP from T.brucei with previously characterized
nucleoplasmins from a number of higher eukaryotes
using ClustalW (Figure 1B). We were able to detect
certain conserved or similar amino acids in the T.brucei
NLP nucleoplasmin-like domain as predicted using
Hidden Markov Models (Pfam). These residues include
a leucine residue at position 557, glycine residues at
positions 560, 562 and 569 and several glutamate
residues in the downstream glutamate-rich region, which
is typical of the nucleoplasmin domain (Figure 1B). This
polyglutamate region is one of the features shared by all
nucleoplasmins, and is also found in T.brucei NLP
(Supplementary Figure S1A). AT-hook domains are
small DNA-binding motifs containing a central glycine–
arginine–proline (GRP) tri-peptide sequence (33,34). In
T.brucei NLP, the AT-hook motif has in addition to the
GRP core, typical lysine and arginine residues preceding
the core as well as other polar residues immediately down-
stream of GRP, including a characteristic lysine residue
in the fourth position downstream (Supplementary
Figure S1B) (34).
Western blot analysis using an anti-NLP antibody
identiﬁed a  120kDA protein in both bloodstream and
procyclic form T.brucei (Figure 1C). This is slightly larger
than the expected size for NLP (predicted to be 107kDa)
but the minor difference in size could be the consequence
of post-translational modiﬁcations. NLP is expressed at
equivalent levels in both life-cycle stages. NLP is an essen-
tial protein in bloodstream form T.brucei, as induction of
Figure 1. NLP is a nucleoplasmin-like DNA-binding protein. (A) Schematic of NLP with protein domains identiﬁed using PROSITE and MyHits
(ISB-SIB). The NLP protein is 957 amino acids with an AT-hook domain extending from residues 214 to 226 represented with a dark blue rectangle,
and a nucleoplasmin-like domain extending from residues 497 to 647 represented with a red rectangle. A glutamate (GLU)-rich region overlaps the
nucleoplasmin-like domain and extends from residues 600 to 671. (B) Alignment using ClustalW of T.brucei NLP with nucleoplasmins from other
eukaryotes. T.brucei NLP is compared with: Drosophila melanogaster Nucleoplasmin (Nlp), zebra ﬁsh (Dario rerio) Nucleoplasmin2, Xenopus laevis
Nucleoplasmin2, Mus musculus Nucleoplasmin1 (Npm1) and Nucleoplasmin3 (Npm3) and Homo sapiens Nucleoplasmin3 (Npm3). Sequence acces-
sion numbers are listed in the ‘Materials and Methods’ section. A conserved region characteristic of nucleoplasmins is shown. Particularly conserved
amino acids are indicated with yellow blocks and asterisks. Amino acids that are conserved in ﬁve to six sequences are highlighted with light blue
blocks, and amino acids which are changed but have similar properties are indicated in green. Double dots indicate conservative and single dots
indicate semi-conservative amino acid changes across all sequences as deﬁned by ClustalW (26). (C) NLP is expressed at approximately equal levels
in both bloodstream form (BF) and procyclic form (PF) T.brucei. Lysates from 1 10
7 cells were analysed on SDS–PAGE gels and the blots were
probed with an antibody against NLP, or the loading control BiP. Size markers in kiloDaltons are indicated on the left. (D) Blocking synthesis of
NLP by the induction of tetracycline inducible RNA interference in bloodstream form T.brucei T3-NLP1 and T3-NLP2 leads to growth arrest within
24 h. Cell lines that have been grown in the presence (+) or absence ( ) of tetracycline are compared. The parental T.brucei T3 cell line is shown for
comparison. (E) Reduction in NLP protein as conﬁrmed by Western blot analysis using an anti-NLP antibody (NLP). Protein lysates were isolated
from T.brucei T3NLP1 after the induction of NLP RNAi with tetracycline (Tet) for the time in hours (h) indicated above. The blot was also probed
with an anti-BiP antibody as a loading control. Size markers in kiloDaltons are shown on the left.
Nucleic Acids Research,2011, Vol.39, No. 6 2021NLP RNAi in the two T.brucei clones T3-NLP1 and
T3-NLP2 leads to an abrupt growth arrest within 24h
of the addition of tetracycline (Figure 1D). Western blot
analysis conﬁrmed the knockdown of the NLP protein to
55% of normal levels by 48h, and to <50% after 72h
induction of NLP RNAi (Figure 1E). Although a clear
growth arrest was observed after the induction of NLP
RNAi, this was not correlated with a signiﬁcant accumu-
lation of cells at any particular stage of the trypanosome
cell cycle (results not shown).
We next made T.brucei cell lines which had an endogen-
ous allele of NLP tagged with the HA epitope (Figure 2A).
Cells with one NLP allele tagged with the HA-epitope
grew as well as the parental T.brucei GPI(VO2+) cell
line. Knocking out the second NLP allele in these lines,
and thereby making the cells dependent on the one
HA-tagged copy of NLP did not lead to an observable
change in cell growth (result not shown). This indicates
that addition of the HA-epitope to the carboxy terminus
of NLP does not observably compromise NLP function.
Microscopic analysis of T.brucei lines with a copy of
HA-tagged NLP showed that NLP is a nuclear protein
with a relatively even distribution through the nucleus
throughout the cell cycle (Figure 2B).
Blocking synthesis of NLP results in derepression of silent
ESs as well as other transcriptionally silent regions
As NLP had originally been identiﬁed as a DNA-binding
protein binding the transcriptionally inactive T.brucei
177-bp repeats, we investigated if it plays a role in
silencing inactive genomic regions. We ﬁrst investigated
its role in maintaining the repressed status of the silent
VSG ESs. The bloodstream form T.brucei T3-SM cell
line has a construct containing eGFP inserted immediately
downstream of the promoter of the silent VSG221 ES
allowing monitoring for ES derepression with ﬂow
cytometry (19) (Figure 3A). In this cell line a blasticidin
resistance gene has been inserted into the VSGT3 ES,
allowing the maintenance of a population homogeneous
for expression of VSGT3 in the presence of blasticidin
selection. We induced RNAi against NLP using tetracyc-
line, and followed ES derepression by ﬂow cytometry.
Induction of NLP RNAi resulted in a striking 45- to
65-fold derepression of the silent VSG221 ES after 72h of
induction of NLP RNAi (Figure 3B). In contrast, ES de-
repression was not observed when we induced RNAi
against the essential DNA binding protein TDP1 (27)
(Supplementary Figure S2), indicating that increased ex-
pression of eGFP was not simply a stress response caused
by the absence of an essential protein or an artefact as a
result of RNAi induced cell death. We also induced RNAi
against NLP in the the T.brucei 121-SM cell line (19). This
is an analogous bloodstream form T.brucei reporter cell
line, with the VSG121 ES active rather than the VSGT3
ES. Here we observed 19- to 52-fold derepression of eGFP
(Supplementary Figure S3).
Given the abundance of NLP in the nucleus, it seemed
unlikely that its biological role was restricted to ES
silencing. We were therefore next interested in determining
the role of NLP in silencing other transcriptionally
inactive areas of the T.brucei genome. In T.brucei, both
rDNA promoters and ES promoters are transcribed by
RNA polymerase I (35). Of the two promoters, transcrip-
tion from the core ES promoter appears to be more sen-
sitive to its chromosomal context. For example, an
exogenous ES promoter was shown to be more compre-
hensively silenced than a comparable rDNA promoter
when inserted in the transcriptionally silent VSG Basic
Copy arrays (36). This observation allows the use of
the ES promoter as a ‘probe’ for repressed chromatin
regions (37).
As T. brucei NLP had originally been identiﬁed as a
protein binding the 177-bp repeats, we investigated its
role in silencing the T.brucei minichromosomes, which
are comprised primarily of arrays of these simple
sequence repeats (38). We therefore integrated a construct
containing an ES core promoter upstream of eGFP
into T.brucei minichromosomes (T.brucei MCEP in
Figure 2. NLP is a nuclear protein. (A) Bloodstream form T.brucei cell
lines expressing HA-epitope tagged NLP were generated (T.brucei HA–
NLP1 and HA–NLP2). Protein lysates from these cell lines were
compared with those from the parental T.brucei GPI(VO2+) cell line
and T.brucei HA–TbISWI as a control for HA antibody speciﬁcity.
(B) HA-epitope tagged NLP localizes to the nucleus. Panels show tryp-
anosomes visualized using differential interference contrast (DIC), the
DNA stain DAPI, or the FITC channel after immunoﬂuorescence
using a rabbit polyclonal anti-HA antibody and an anti-rabbit
Alexa-488 secondary antibody. Cells containing either one kinetoplast
(K) and one nucleus (N) (1K1N) or precytokinesis cells containing two
kinetoplasts and two nuclei (2K2N) are shown.
2022 Nucleic Acids Research, 2011,Vol.39, No. 6Figure 4A). The blasticidin resistance gene used for selec-
tion in this construct is driven by an rDNA promoter.
Induction of NLP RNAi resulted in 5–6-fold derepression
of eGFP, indicating that NLP plays a role in silencing the
minichromosomal 177-bp repeat regions. Although the
degree of derepression is  10-fold higher in the T. brucei
T3-SM line compared with the MCEP line, the FL1-H
signal after 72h induction of NLP RNAi is comparable.
This is explained by the low basal level of transcription
from the ES promoter inserted into a transcriptionally
silent minichromosome (as seen in the FACS trace for
time point 0 in Figure 4A). An equivalent T.brucei
reporter line which contained a construct without an
ES promoter upstream of eGFP inserted into
minichromosomes was also tested. Induction of NLP
RNAi in this second cell line did not result in a signiﬁcant
increase in eGFP transcription (data not shown). This in-
dicates that although blocking the synthesis of NLP
appears to facilitate transcription from the ES promoter,
it does not lead to a signiﬁcant increase in fortuitous ini-
tiation of transcription from cryptic promoters at
minichromosomes.
As it had earlier been shown that the ES promoter is
particularly repressed if integrated into the VSG Basic
Copy arrays of bloodstream form T.brucei (36), we next
investigated the role of NLP in silencing this area of the
genome. The VBEP construct, containing an ES promoter
upstream of eGFP, was integrated upstream of the silent
VSG118 Basic Copy gene (Figure 4B). As seen after
integrating an exogenous ES promoter in the
minichromosomes, there is a low rate of transcription
from an ES promoter integrated into the VSG Basic
Copy arrays. Blocking synthesis of NLP led to a  5-fold
derepression of eGFP by 72h (Figure 4B). As in the
minichromosome targeting experiments, a comparable
reporter line containing a construct without an ES
promoter upstream of eGFP inserted upstream of the
VSG118 Basic Copy gene did not show signiﬁcantly
increased transcription of eGFP after the induction of
NLP RNAi (result not shown). Therefore, although
NLP appears to play a role in establishing the repressive
chromatin environment silencing the exogenous ES
promoter in the VSG Basic Copy arrays, depleting its
synthesis does not result in a signiﬁcant increase in
fortuitous initiation of transcription from cryptic pro-
moters in this genomic region. Our observed derepression
of eGFP is not simply the consequence of a lethal pheno-
type, as induction of RNAi against the essential TDP
protein in the T.brucei MCEP and VBEP cell lines did
not lead to an increase in eGFP transcription (27)
(results not shown).
Lastly, the role of NLP was investigated in silencing
procyclin genes, which are to a great extent transcription-
ally inactive in bloodstream form T.brucei (39,40). We
used a cell line where a reporter construct was integrated
behind the silent EP1 promoter in bloodstream form
T.brucei. Although procyclin protein is not detectably ex-
pressed in bloodstream form T.brucei, there is a small
amount of transcription from procyclin promoters. This
explains the observed eGFP ﬂuorescence in the FACS
trace at time point 0 in Figure 4C. Blocking synthesis of
NLP leads to a  4-fold increase in transcription of eGFP
driven by the silenced EP1 promoter (Figure 4C). In
summary, blocking the synthesis of NLP had the most
spectacular effect on derepressing silent VSG ESs in
bloodstream form T.brucei. However, it also appears to
play a role in establishing a repressive transcriptional en-
vironment for the ES promoter in bloodstream form
T.brucei at different genomic regions, including the tran-
scriptionally silent T.brucei minichromosomes, the VSG
Basic Copy arrays and the inactive EP1 transcription
units.
Figure 3. Blocking synthesis of NLP in bloodstream form T.brucei
results in derepression of the silent VSG221 ES. (A) Schematic of the
T.brucei T3-NLP line. The large box indicates a trypanosome which
expresses VSGT3 from the active VSGT3 ES (transcription indicated
with an arrow). A blasticidin resistance gene has been inserted imme-
diately downstream of the active VSGVT3 ES promoter (indicated with
a white ﬂag), allowing maintenance of a population homogeneous for
VSGT3 expression through selection on blasticidin. The silent VSG221
ES has eGFP inserted immediately behind the promoter. ES derepres-
sion can be monitored after the induction of NLP RNAi from tetra-
cycline inducible T7 promoters (black ﬂags). (B) The silent VSG221 ES
is 45–65-fold derepressed after the induction of NLP RNAi with tetra-
cycline (Tet) for the time indicated in hours (h). T.brucei T3-NLP1 and
T.brucei T3-NLP2 are compared with the parental T.brucei VSGT3
expressor (T3). Above are representative ﬂow-cytometry traces in the
FL1 channel after the induction of NLP RNAi for 0 or 72 h. Below is a
graph showing the fold derepression at each time point calculated by
dividing the mean ﬂuorescence of a tetracycline induced culture with an
uninduced culture at the same time point. Error bars show the standard
deviation between three experiments.
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regions of the T.brucei genome
We next attempted to determine where NLP binds in the
T.brucei genome using ChIP experiments. For this
purpose, we used bloodstream form T.brucei cell lines
where the carboxy terminus of one NLP allele had been
epitope tagged with the HA epitope (Figure 2A). We
cross-linked chromatin using formaldehyde in blood-
stream form T.brucei, and used an antibody against the
HA-tag to immunoprecipitate NLP-HA cross-linked to
DNA. As a positive control, we also performed the
ChIP experiment with an antibody to histone H3, or as
a negative control performed the ChIP procedure without
using an antibody (18). The ChIP procedure was also
carried out using the parental T.brucei 221GPI(VO2+)
cells to provide an additional negative control for speciﬁ-
city of the anti-HA antibody.
As NLP had originally been identiﬁed binding the
177-bp repeats, we ﬁrst investigated its distribution on
these sequences. Slot blot analysis showed that NLP
indeed binds the 177-bp repeats (Figure 5A). In
addition, NLP was found binding the 50-bp repeats
which extend as large arrays upstream of all known T.
brucei ESs, at levels that were  3- to 4-fold background,
with non-overlapping error bars indicating standard devi-
ation (Figure 5A). We also analysed the presence of NLP
in various other genomic locations. Quantitative PCR
(qPCR) was performed on the input chromatin, as well
as immunoprecipitated material from the T.brucei NLP–
HA and parental cell lines to detect the presence of NLP.
Schematics of the different transcription units investigated
are shown in Figure 5. NLP was found at the spliced
leader (SL) genes transcribed by RNA polymerase II
(Figure 5B and D) (41) as well as at the 5S rRNA tran-
scription units transcribed by RNA polymerase III
(Figure 5C and D). Here also, we found relatively high
amounts of NLP binding both in the intergenic spacers
and within the genes themselves.
Figure 4. NLP plays a role in silencing transcriptionally inactive
regions of the bloodstream form T.brucei genome. (A) Blocking syn-
thesis of NLP leads to derepression of an ES promoter located in a
transcriptionally silent minichromosome (Mini-chrom). A construct
containing an ES promoter (white ﬂag) was inserted into a T.brucei
minichromosome using characteristic 177-bp repeat sequences which
make up the bulk of the minichromosomes (diagonally hatched box).
Silent VSGs are located at the telomeres, which are indicated with
horizontal triangles. The blasticidin resistance gene (Blast) used for
selection is driven by an rDNA promoter (black ﬂag). The T.brucei
MCEP-NLP1 and MCEP-NLP2 lines were monitored for derepression
of the ES promoter using ﬂow cytometry after the induction of NLP
RNAi with tetracycline (Tet) for the time indicated in hours (h).
Analysis of the parental T.brucei MCEP line is shown for comparison.
Characteristic FACS traces are shown above. The results are the mean
of triplicate NLP RNAi experiments with the standard deviation
indicated with error bars. (B) Blocking synthesis of NLP leads to de-
repression of an ES promoter inserted into a transcriptionally silent
VSG Basic Copy (BC) array. The experiment was performed as in
(A) where a similar construct containing an ES promoter was
inserted into the VSG118 Basic Copy array, with VSGX, MiTat1.100
and VSG118 indicated with coloured boxes. Derepression of eGFP was
monitored by ﬂow cytometry. Above are representative ﬂow cytometry
traces after the induction of NLP RNAi with tetracycline. The T.brucei
VBEP-NLP1 and T.brucei VBEP-NLP2 cell lines are compared with
the parental T.brucei VBEP line. (C) Induction of NLP RNAi results
in derepression of an endogenous procyclin EP1 promoter in blood-
stream form T.brucei. The EP1 promoters (including the duplicated
EP1 promoter from the construct) are indicated with red ﬂags.
Similar to panels (A) and (B), derepression of eGFP was monitored
by ﬂow cytometry after the induction of NLP RNAi with tetracycline
for the time indicated. The T.brucei EP1-NLP1 and EP1-NLP2 lines
are compared with the parental T.brucei EP1 cell line.
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as well as the rDNA in T.brucei (35). First NLP distribu-
tion within the rDNA was determined. Relatively low
levels of NLP were found within the rDNA transcription
unit (primers 2b, 2d, 2f and 2g in Figure 5E and G).
However, levels of NLP were enriched in the
non-transcribed rDNA spacer either upstream or down-
stream of a given rDNA transcription unit (primers 2a
and 2l; Figure 5E and G). Compared with levels of NLP
in the 18S or 28S rDNA, levels of NLP were over 3-fold
higher using primer pair 2a and nearly 3-fold using primer
pair 2l. An approximately 3-fold higher level of NLP was
also found upstream of the procyclin EP1 and EP2
transcription units (primer 3a in Figure 5F and G)
compared to within the EP1 gene itself (primer 3c and
3e). In summary, in a variety of T.brucei transcription
units, higher levels of NLP are found binding the
adjacent transcriptionally silent regions compared to
within the transcription units themselves.
As downregulation of NLP leads to striking levels of
derepression of silent ESs, we next investigated its
binding to ES sequences (Figure 6). As ESs are highly
similar to each other in sequence (12), primers can be
expected to bind most if not all ESs. To circumvent this
problem, we performed ChIP in a bloodstream form
T.brucei line that contained a single copy neomycin
Figure 5. ChIP experiments show enrichment of NLP in simple sequence repeats as well as the non-transcribed regions around the rDNA and
procyclin loci. The bloodstream form T.brucei HA–NLP cell line containing one allele of NLP tagged with the HA epitope (HA–NLP) (red bars), or
the parental wild-type cell line (WT) (blue bars) was used. In all of these experiments immunoprecipitation with an anti-HA antibody was performed,
and the relative amount immunoprecipitated is shown after subtraction of the values quantitated in a corresponding ChIP experiment performed in
the absence of antibody. Primer pairs used for quantitative PCR (qPCR) in these ChIP experiments are indicated with numbered brackets, and are
described in (18) or Supplementary Table S1. All graphs show the mean of triplicate ChIP experiments, with standard deviation indicated with error
bars. (A) NLP is enriched on the 177-bp repeats comprising T. brucei minichromosomes, as well as the 50-bp repeats present upstream of all known
ESs. Representative slot blots of immunoprecipitated chromatin hybridized with probes for the relevant repeat region are shown. Material from the
parental cell line (WT) is compared with that from the HA–NLP line (HA). Total input (Total In) is compared with material precipitated either with
an anti-histone H3 antibody (a-His H3), no antibody (No Ab) or an anti-HA epitope antibody (a-HA). A graph showing the amounts immunopre-
cipitated (after subtraction of the no antibody control) is indicated below the slot blot. Error bars indicate the standard deviation from three
independent experiments. (B) Schematic diagram showing the spliced leader (SL) RNA transcription units transcribed by RNA polymerase II. The
relevant genes are indicated with black boxes, with the SL promoters indicated with ﬂags. (C) Diagram of the 5S rRNA locus transcribed by RNA
polymerase III. The 5S genes and pseudo-gene (c) are indicated with black boxes and the 5S promoters with ﬂags. (D) Quantitation of ChIP results
using the T.brucei HA–NLP and parental wild-type (WT) cell lines. Immunoprecipitation with an anti-HA antibody was performed, and the relative
amount of SL DNA or 5S rDNA immunoprecipitated is shown after subtraction of the values quantitated in a corresponding ChIP experiment using
no antibody. (E) Diagram of a typical Pol I transcribed ribosomal DNA (rDNA) locus with the rDNA promoter indicated with a ﬂag. (F) Schematic
of the Pol I transcribed procyclin EP locus with two tandem EP genes indicated with black boxes. The EP promoter is indicated with a ﬂag. (G)
Quantitation of ChIP results as in D). Immunoprecipitation with an anti-HA antibody was performed, and the relative amount of rDNA or
procyclin DNA immunoprecipitated is shown.
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of the active VSGVO2 ES, as well as a construct contain-
ing a puromycin resistance gene and eGFP behind the
silent VSG221 ES promoter (Figure 6B). The VSG
pseudogene (c) and the VSG221 gene are additional
single copy sequences present within the silent VSG221
ES. All of the common ES primers used (‘All ESs’ in
Figure 6C) can be expected to recognise the active as
well as most if not all of the silent ESs. Although we
were able to ﬁnd a low amount of NLP binding within
the ES promoter region (primer 4c in Figure 6C), we could
not distinguish between active and silent ESs with this
primer set. qPCR analysis using single copy sequences
speciﬁc for either the active or silent ES showed NLP
binding to both silent and active ESs along the length of
the telomere.
The levels of NLP immunoprecipitated in our experi-
ments are low, but comparable to those observed for some
chromatin remodeling proteins in other systems, for
example ISWI in Drosophila (42,43). Typically, in our
Figure 6. NLP is relatively depleted at ES promoters but binds both active and silent ESs. ChIP experiments were performed with the T.brucei
HA–NLP and parental wild-type (WT) cell lines. (A) A schematic of a typical ES is shown above with the ES promoter shown with a ﬂag, and
characteristic Expression site associated genes (ESAGs) indicated with ﬁlled boxes. The immediate area around the ES promoter is expanded below.
Characteristic 50-bp repeat arrays ﬂanking the ES promoter, or 70-bp repeat sequences present upstream of the telomeric VSG are indicated with
vertically striped boxes. Primers used are as described in (18). As ESs are multi-copy and highly similar, these primers can be expected to recognise
most if not all ESs. (B) Schematic of the T.brucei HA–NLP cell line used for ChIP. Transcription of the active VSGVO2 ES from the ES promoter
(ﬂag) is indicated with an arrow. The single copy neomycin resistance gene is indicated (Neo). The silent VSG221 ES contains a construct containing
a puromycin resistance gene (Pur) and eGFP. Other single copy genes are the single copy VSG pseudogene (c), as well as VSG221. These single copy
genes are indicated with ﬁlled boxes. Relevant primers are indicated with numbered brackets. Primers used are as described in (18) or in
Supplementary Table S1. (C) Quantiﬁcation of the immunoprecipitated material using an anti-HA antibody to detect the HA-epitope tagged
NLP using either the T. brucei HA–NLP cell line (HA–NLP) (red bars) or the wild-type cell line (WT) (blue bars) after subtraction of the no
antibody control as described in Figure 5. Results are the mean of triplicate ChIP experiments, with standard deviation indicated with error bars.
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30-fold enriched over background levels obtained after
immunoprecipitation with an anti-HA antibody in
wild-type cell line. The relative inefﬁciency of NLP ChIP
compared with the histone H3 ChIP control (results not
shown) (18), is presumably due to the relatively low
afﬁnity of NLP for DNA, as one might expect for a
nucleoplasmin-like protein compared with a histone or a
speciﬁc transcription factor.
Depletion of NLP leads to reduced transcription of the
active ES
As induction of NLP RNAi resulted in 45- to 65-fold de-
repression of an eGFP gene present immediately down-
stream of the inactive VSG221 ES promoter, we next
wanted to know if this derepression led to fully processive
ES transcription resulting in full activation of silent ESs or
increased VSG ES switching. Total RNA was isolated
from bloodstream form T.brucei NLP1 after the induction
of NLP RNAi for different time points, cDNA was
prepared and levels of various transcripts were monitored
by qPCR. As expected, induction of NLP RNAi led to a
reduction in NLP transcript down to  25% normal levels
by 48h (Figure 7). Also as expected from the ﬂow
cytometry data which showed an increase in eGFP
protein (Figure 3), eGFP transcript from the derepressed
VSG221 promoter increased almost 20-fold after the in-
duction of NLP RNAi. However, despite the striking de-
repression of the VSG221 ES promoter observed after the
induction of NLP RNAi, there was no signiﬁcant increase
in the VSG transcripts themselves from a selection of six
silent VSG ESs. VSG transcripts monitored include those
from the VSG13, VSG121, VSG224, VSG800, VSGbR2
and VSGJS1 ESs (12,44). VSG transcripts from silent
ESs were particularly low after the induction of NLP
RNAi for 48h. The subsequent increase in these tran-
scripts at 72h could be a consequence of increases in
levels of NLP, possibly as a result of the emergence of
revertants escaping a lethal RNAi phenotype.
A striking observation from these experiments is that
the level of the active VSGT3 transcript itself fell drastic-
ally to 4% normal levels after 48h induction of NLP
RNAi. Levels of transcript from the blasticidin resistance
gene present in the active VSGT3 ES also fell almost
Figure 7. Quantitation of transcripts in the T.brucei T3-NLP1 cell line after the induction of NLP RNAi with tetracycline (Tet) for the time
indicated in hours (h). RNA was collected from cells at different time points, cDNA was prepared and qPCR was performed to monitor changes in
transcript levels. Data was normalized to the level of actin transcript at each time point, and is plotted as the fold difference between the induced and
uninduced time points. Relative levels of transcript after the induction of NLP RNAi are shown for: NLP, eGFP present in the silent VSG221 ES, a
representative number of silent ES-located VSGs, VSGT3 and the blastidin resistance gene (Blast) present in the active VSGT3 ES, EP1 procyclin,
spliced leader and the genes encoding actin and the large subunit of RNA polymerase I. The silent VSGs are all located at the telomeres of silent ESs,
and are: VSG13, VSG121, VSG224, VSG800, VSGbR2 and VSGJS1 (12,44). All data shown are the mean of triplicate RNAi induction experiments
with standard deviation represented with error bars. The data was normalized against the values for actin transcript shown in this ﬁgure, with the
exception of the quantitation of the EP1 procyclin transcript, which was part of a separate triplicate experiment and normalized to an independent
quantitation of actin.
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results indicate that NLP plays an important role in
facilitating fully processive transcription from the active
VSG ES as well as silencing the silent ESs. This lack of
processive transcription from the active ES in the face of
an NLP synthesis block could explain why transcripts
from silent VSG ESs also appear reduced after 48h.
Levels of VSG transcripts from the active and silent
VSGs were comparable irrespective of whether the cells
had been maintained on blasticidin selection to select for
continued expression of VSGT3. These results were also
conﬁrmed using an analogous bloodstream form T.brucei
cell line expressing VSG121 rather than VSGT3 from the
active ES, even though the degree of NLP knockdown
was less pronounced in this cell line (Supplementary
Figure S4).
Transcripts derived from the Pol I transcribed EP1
procyclin genes increased  5-fold after the induction of
a block in NLP synthesis (Figure 7), in agreement with the
observed derepression of the EP1 procyclin promoter (see
Figure 4C). In these experiments performed in triplicate,
transcript amounts are presented as normalized to the
amount of actin transcript present at each time point.
As a reference point, the amount of actin transcript
quantitated at each time point after the induction of
NLP RNAi is also shown (Figure 7). Quantitated levels
of the spliced leader or the transcripts encoding actin or
the RNA polymerase I large subunit did not change sig-
niﬁcantly after NLP knockdown (Figure 7).
DISCUSSION
Here we describe a novel transcription regulatory protein
NLP, which is essential, and has a nucleoplasmin-like
domain and an AT-hook motif. T.brucei NLP plays a
key role in ES control, as blocking its synthesis leads to
45- to 65-fold derepression of silent ESs. NLP also plays
a role in silencing other transcriptionally inactive
areas in bloodstream form T.brucei including the
minichromosomes, the VSG Basic Copy arrays and the
procyclin locus. Using ChIP analysis, NLP was found to
bind simple sequence repeats as well as certain silent areas
around Pol I transcription units in the T.brucei genome.
However, despite the observed derepression of silent ESs
after the induction of NLP RNAi, we did not ﬁnd
evidence that NLP preferentially binds silent ESs. Also,
in spite of the striking degree of derepression of ES
promoters observed after NLP knockdown, we did not
ﬁnd fully processive transcription of silent ESs or an ob-
servable increase in ES switching. Blocking synthesis of
NLP resulted in a drastic reduction in processive tran-
scription of the active ES. As one needs to have full acti-
vation of silent ESs in order to see an increase in VSG ES
switching, the observed lack of change in VSG switching
could be a consequence of the lack of processive transcrip-
tion in the derepressed silent (as well as active) VSG ESs.
It has only recently become apparent that ES regulation
in bloodstream form T.brucei involves chromatin re-
modeling. It is now clear that the active ES in bloodstream
form T.brucei is radically depleted in nucleosomes
compared with the silent ESs (17,18). Therefore chromatin
remodeling is highly likely to be involved in the conversion
of an ES from its silent to active state. The ﬁrst chromatin
remodeler identiﬁed to be involved in ES silencing in
T.brucei was TbISWI, which is a member of the SNF2
superfamily of ATP-dependent chromatin remodeling
complexes (19). Knockdown of TbISWI results in
30–60-fold derepression of silent ESs. In addition, the
telomere binding protein TbRAP1 is involved in a
gradient of silencing operating at and increasing in
strength towards the ES chromosome end (20). Blocking
synthesis of TbRAP1 results in an increase in ES switching
as well as ES promoter derepression. Lastly, the histone
methyltransferase DOT1B appears to be essential for
mono-allelic expression of VSG (21). Inhibition of
DOT1B synthesis results in silent ESs becoming partially
derepressed, with the full switch from one ES to another
occurring at a slower rate than average.
NLP does not closely resemble known chromatin re-
modeling proteins in other eukaryotes, and is a new
addition to the small list of proteins shown to be
involved in ES control in T.brucei. One of its distinctive
features is a nucleoplasmin motif, which is similar in size
to a typical nucleoplasmin protein. Nucleoplasmins are
small ( 150–300 amino acids) acidic proteins which
function as histone chaperones (45,46). Nucleoplasmin
was originally identiﬁed in Xenopus oocytes as a highly
abundant protein which can assemble nucleosome cores
in vitro from puriﬁed histones and DNA (31).
Nucleoplasmin mediates sperm chromatin decondensation
in Xenopus where it binds and removes sperm basic
proteins and replaces them with histones H2A and H2B
(47,48). In addition, nucleoplasmin has been shown to be
important for regulating the chromatin condensation that
occurs during apoptosis (49). In Drosophila a
nucleoplasmin like protein (dNLP) binds to core
histones, and functions in assembling regularly spaced nu-
cleosomal arrays in an ATP-dependent fashion (50).
Is NLP a nucleoplasmin? Nucleoplasmins are typically
small phosphoproteins which can function as pentamers
(51). NLP at almost 1000 amino acids is more than ﬁve
times bigger than a typical nucleoplasmin. In addition, it
contains a non-typical AT-hook domain. AT-hook motifs
are small ( 11 amino acid) DNA binding motifs centred
around a GRP tripeptide, which is necessary and sufﬁcient
to mediate DNA binding (33). This motif typically func-
tions as an auxiliary protein motif, which in conjunction
with other DNA binding motifs in the same protein facili-
tates binding to DNA (34). The AT-hook motif has also
been found in a very wide variety of different DNA
binding proteins including transcription regulators and
co-factors of different DNA binding proteins (34).
T.brucei NLP does not appear to be a nucleoplasmin in
the strict sense of the word, but the homology to this type
of protein could indicate that it interacts with histones in
trypanosomes. Further experiments will be required to
address this issue.
What is the role of NLP in the mono-allelic exclusion of
ESs in bloodstream T.brucei? NLP was originally
identiﬁed in DNA afﬁnity chromatography experiments
using procyclic form T.brucei extracts, and is not
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with being a general transcription regulator, levels of NLP
protein appear to be equivalent in both procyclic and
bloodstream form T.brucei life-cycle stages. In blood-
stream form trypanosomes, in addition to its importance
for the establishment of ES silencing, NLP also plays a
role in silencing other transcriptionally inactive regions
including the minichromosomes, VSG Basic Copy arrays
and the procyclin loci. This indicates that NLP is a general
transcription regulator, and is not uniquely involved in ES
control. This is consistent with its localisation in ChIP
experiments to the rDNA non-transcribed spacer, and
the region upstream of the Pol I transcribed procyclin
loci. In the ES itself, NLP appears to bind both silent
and active ESs indicating that it could play a functional
role in both locations.
Compatible with this observation, knockdown of NLP
synthesis resulted in reduced transcription from the active
Pol I transcribed ES itself. This phenomenon was not
observed with the Pol II transcribed actin, tubulin or
RNA polymerase I large subunit transcripts. It is
possible that chromatin remodeling is required to
maintain transcription of the regulated ESs, which are
transcribed in trypanosomes at a very high rate. In
contrast, there does not appear to be signiﬁcant transcrip-
tional regulation of the Pol II transcribed arrays of house-
keeping genes. NLP could have chromatin remodeling
activity which is important for maintaining fully
processive transcription of the active ES. This could, for
example, operate through facilitating removal of histones
including histone H3, which has been shown to be particu-
larly depleted from the active ES (17,18). These different
activities of NLP argue that it plays a role in both
facilitating and inhibiting transcription. There is precedent
for this, as the ISWI complexes in other eukaryotes
provide a good example of a chromatin factor involved
in both transcription repression and activation within a
single cell. In Saccharomyces cerevisiae the Isw1a
complex (consisting of Isw1p and Ioc3p) is involved in
transcription silencing, while the Isw1b complex (consist-
ing of Isw1p together with Ioc2p and Ioc4p) is involved in
transcription elongation (52).
A challenge will come in determining how NLP inter-
acts with other chromatin remodeling proteins and histone
modiﬁcation enzymes including ISWI, RAP1 and DOT1B
in maintaining ES control. It is likely that multiple
silencing gradients operate simultaneously on silent ESs
in T.brucei (20,53). A relatively short distance repressive
gradient extends up from the T.brucei ES telomere, and
involves the sirtuin protein SIR2 (54,55). SIR2 is involved
in repression operating in the immediate proximity of the
telomere repeats, but does not appear to play a role in the
long distance repressive effect operating over many tens of
kilobases, necessary for control of the ES promoter (55).
In contrast, the telomere binding protein RAP1
establishes a silencing gradient operating over much
longer distances including the ES promoter, and
increasing in intensity closer to the ES telomere (20).
Blocking RAP1 synthesis results in derepression of silent
ESs, and an increase in transcripts from VSGs located at
silent ES telomeres.
Blocking NLP synthesis results in derepression of a
silent ES promoter but no observable increase in VSG
switching. One possibility is that NLP is involved in es-
tablishing or maintaining repressed chromatin in the im-
mediate vicinity of the ES promoter. Blocking NLP
synthesis could possibly result in promoter derepression,
but as the derepressed chromatin is relatively localized, the
Pol I does not transcribe in a processive fashion down to
the telomere end. This could be the consequence of a
second repressive gradient (possibly mediated by RAP1)
impeding the elongating RNA polymerases. A complica-
tion with interpreting our ﬁndings however is the fact that
transcription of the active ES itself is impeded by NLP
knockdown. This implies that NLP could be involved in
establishing the chromatin environment necessary for the
elongating Pol I transcription complex. A challenge for
the future will be in unravelling the interplay of the
multiple regulatory factors implicated in ES control.
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